RICCI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 9.755
AS - Asia 3.476
EU - Europa 2.273
SA - Sud America 777
AF - Africa 273
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.563
Nazione #
US - Stati Uniti d'America 7.293
CA - Canada 2.421
SG - Singapore 1.144
CN - Cina 956
HK - Hong Kong 734
BR - Brasile 664
IT - Italia 626
DE - Germania 401
SE - Svezia 302
VN - Vietnam 286
BG - Bulgaria 222
GB - Regno Unito 182
CI - Costa d'Avorio 164
RU - Federazione Russa 153
FI - Finlandia 108
TR - Turchia 72
IN - India 57
FR - Francia 55
AT - Austria 52
AR - Argentina 39
BD - Bangladesh 38
UA - Ucraina 35
JP - Giappone 34
IQ - Iraq 26
ZA - Sudafrica 26
KR - Corea 25
NG - Nigeria 24
SN - Senegal 23
ES - Italia 22
ID - Indonesia 21
MX - Messico 21
NL - Olanda 20
BE - Belgio 17
EC - Ecuador 17
PL - Polonia 16
VE - Venezuela 12
CO - Colombia 11
UY - Uruguay 11
CH - Svizzera 10
SA - Arabia Saudita 10
CZ - Repubblica Ceca 9
IE - Irlanda 9
MA - Marocco 9
PH - Filippine 9
PY - Paraguay 9
PK - Pakistan 8
GR - Grecia 7
IL - Israele 6
JO - Giordania 6
LT - Lituania 6
AZ - Azerbaigian 5
BO - Bolivia 5
CL - Cile 5
EG - Egitto 5
KE - Kenya 5
MY - Malesia 5
NP - Nepal 5
UZ - Uzbekistan 5
AU - Australia 4
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
IR - Iran 4
PE - Perù 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
JM - Giamaica 3
AM - Armenia 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
TG - Togo 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AL - Albania 1
AO - Angola 1
BJ - Benin 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
Totale 16.554
Città #
Montreal 2.314
Ashburn 774
Hong Kong 720
Woodbridge 625
Singapore 618
Fairfield 605
Dallas 582
Houston 565
Santa Clara 554
Ann Arbor 497
Chandler 423
Seattle 311
Shanghai 285
Beijing 243
Wilmington 241
Sofia 221
Cambridge 205
New York 180
Abidjan 164
Serra 125
Boardman 122
Los Angeles 117
Princeton 113
Lawrence 97
Medford 86
Ottawa 80
Ho Chi Minh City 71
Munich 68
Milan 66
Florence 64
São Paulo 55
Des Moines 49
Redondo Beach 47
Hefei 45
Rome 43
Vienna 41
Jacksonville 39
Ogden 39
Turku 39
Istanbul 37
Buffalo 36
Hanoi 35
Dong Ket 34
Lancaster 34
Nanjing 34
San Diego 32
London 31
Frankfurt am Main 25
Tokyo 25
Pisa 24
Dakar 23
Lagos 23
Bremen 22
Columbus 22
Rio de Janeiro 22
The Dalles 21
Seoul 20
Helsinki 19
Shenyang 19
Hebei 18
Izmir 18
Nanchang 18
Redwood City 18
Belo Horizonte 16
Dearborn 16
Düsseldorf 16
Nuremberg 16
Brussels 15
Council Bluffs 14
Fuzhou 14
Jiaxing 14
San Francisco 14
Norwalk 13
Genoa 12
Johannesburg 12
Kunming 12
Nürnberg 12
Warsaw 12
Chicago 11
Jüchen 11
Montevideo 11
Phoenix 11
San Jose 11
Toronto 11
Campinas 10
Curitiba 10
Guangzhou 9
Mexico City 9
New Delhi 9
Porto Alegre 9
Brooklyn 8
Dhaka 8
Dublin 8
Fortaleza 8
Guayaquil 8
Kent 8
Sheffield 8
Tulsa 8
Baghdad 7
Cascina 7
Totale 12.551
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.486
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 284
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 262
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 232
Metabolic myopathies: functional evaluation by different exercise testing approaches 224
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 206
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 196
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 193
Inflammatory myopathy in a patient with postural and kinetik tremor. 193
Mitochondria and neurodegeneration 189
Astrocyte-neuron interactions in neurological disorders 186
Congenital myopathies: Clinical phenotypes and new diagnostic tools 183
Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 183
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 182
A personal monitoring architecture to detect muscular fatigue in elderly. 178
Study of the porcine dermal collagen repair patch in morpho-functional recovery of the rotator cuff after minimum follow-up of 2.5 years 174
NMR voxel-based morphometry and functional analysis as neural correlates of neuropsychological dysfunction in DM1 174
Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis 166
ClC-1 mutations in myotonia congenita patients: Insights into molecular gating mechanisms and genotype-phenotype correlation 165
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study 164
Physical exercise and oxidative stress in muscular dystrophies: is there a good balance? Exercise and oxidative stress in MDs 163
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 163
A mobile app for patients with Pompe disease and its possible clinical applications 163
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. 162
Folate, homocysteine, vitamin B12 and polymorphisms of genes participating in one-carbon metabolism in late onset Alzheimer's disease patients and healthy controls. 162
A pervasive activity management and rehabilitation support system for the elderly 162
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 156
Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. 155
A wearable pervasive platform for intelligent monitoring of muscular fatigue 153
Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication 153
LMNA-associated myopathies: the Italian experience in a large cohort of patients 151
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. 148
The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1 146
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 145
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 142
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry 142
Tubular Aggregates Myopathy: case description 138
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 136
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group. 136
Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes 132
CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. 131
Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. 131
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 129
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients 129
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 128
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations. 125
The empowerment of translational research: lessons from laminopathies 125
A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene 124
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study 123
The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients 123
A multi-parametric protocol to study exercise intolerance in McArdle's disease 121
Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy 121
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates 119
An Ontology-driven Multisensorial Platform to Enable Unobtrusive Human Monitoring and Independent Living 118
"I have got something positive out of this situation": Psychological benefits of caregiving in relatives of young people with muscular dystrophy 118
Facioscapulohumeral muscular dystrophy: New insights from compound heterozygotes and implication for prenatal genetic counselling 115
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 115
Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders 115
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study 112
Facioscapulohumeral muscular dystrophy: more complex than it appears 105
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 104
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 104
Exercise therapy in muscle diseases: open issues and future perspectives 104
Cardiac magnetic resonance in patients with muscular dystrophies 103
A Single mtDNA Deletion in Association with a LMNA Gene New Frameshift Variant: A Case Report 102
Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons 101
Novel LMNA gene mutation in a patient with cardiac and skeletal muscle involvement 100
FUNCTIONAL DIAGNOSTICS IN MITOCHINDRIAL DISEASES 99
A case of intravascular large B cell lymphoma with brain involvement mimicking progressive multifocal leukoencephalopathy 97
A 5-year clinical follow-up study from the Italian National Registry for FSHD 96
The role of magnetic resonance imaging in the diagnostic work-out of myopathies: differential diagnosis between inflammatory myopathies and muscular dystrophies 93
Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy 93
Biomolecules of Muscle Fatigue in Metabolic Myopathies 92
Mitochondrial DNA transcription and translation: Clinical syndromes 92
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1 92
Chronic inflammatory demyelinating polyneuropathy associated with multiple sclerosis 91
Fatigue as a common signature of inflammatory myopathies: clinical aspects and care 91
Posterior reversible encephalopathy syndrome in a complicated autoimmune background: Differential diagnosis and etiological hypothesis 90
Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity 89
Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients 89
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"? 89
Response. 88
null 88
Convolutional Neural Network-Based Automated Segmentation of Skeletal Muscle and Subcutaneous Adipose Tissue on Thigh MRI in Muscular Dystrophy Patients 87
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 87
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillar and Distal Myopathies 82
null 81
Pathophysiology and Management of Fatigue in Neuromuscular Diseases 80
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 80
Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA/4qA and 4qA/4qB patients 79
The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME 79
Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence? 78
Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis 78
Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report 76
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 75
Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction 73
Psychosocial impact of sport activity in neuromuscular disorders 73
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 73
Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients 73
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort 72
Totale 15.168
Categoria #
all - tutte 44.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021512 0 0 0 0 0 71 70 45 88 49 39 150
2021/2022983 21 48 23 69 161 129 27 51 45 41 73 295
2022/20231.390 151 175 87 104 149 149 10 100 320 8 109 28
2023/20243.170 46 75 85 32 121 132 98 39 26 2.333 63 120
2024/20253.690 13 125 84 193 398 408 344 205 352 470 371 727
2025/20262.984 320 587 702 550 453 372 0 0 0 0 0 0
Totale 16.750